Algeria HIV AIDS Industry Outlook 2022 - 2026

See how Algeria HIV AIDS performed compared to key markets such as South Africa, Nigeria and Mozambique.

Key Market Indicators

The prevalence of HIV/AIDS in Algeria is set to reach 1,050 people aged 0-14 by 2026, a 3.1% year-on-year increase on the 862 people aged 0-14 in 2021. Since 1995, demand has grown by 11.5% each year. In 2021, Algeria ranked 61st in the world, behind Morocco with 862 people aged 0-14. Nigeria, Mozambique and Tanzania took 2nd, 3rd and 4th place respectively. The treatment coverage of people living with HIV in Algeria hit 90% in 2021, a 5.9 point rise from the 85% in 2020. Since 2005, the market has grown by 3.2 points each year. In 2021, Algeria was 12th in the world, behind Australia with 90% coverage. Cape Verde, Latvia and Zimbabwe came in 2nd, 3rd and 4th place respectively.

Algeria HIV AIDS Market Data and Forecasts

How much will Algeria HIV AIDS Market grow to 2026?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Algeria
Forecast: Incidence of HIV Among People Aged 15-24 in Algeria
Forecast: Estimated AIDS Deaths in Algeria

Other Top Countries about HIV AIDS